Published in Oncol Lett on March 11, 2014
Global cancer statistics, 2002. CA Cancer J Clin (2005) 119.22
Angiogenesis in cancer and other diseases. Nature (2000) 28.28
Hepatocellular carcinoma. Lancet (2003) 22.54
Hepatocellular carcinoma. Lancet (2012) 18.09
Primary liver cancer: worldwide incidence and trends. Gastroenterology (2004) 11.21
Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods (1989) 9.42
Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc Natl Acad Sci U S A (1983) 7.55
Angiogenesis and tumor metastasis. Annu Rev Med (1998) 3.08
Systematic review: evidence-based management of hepatocellular carcinoma--an updated analysis of randomized controlled trials. Aliment Pharmacol Ther (2006) 2.63
Epidemiology and natural history of hepatocellular carcinoma. Best Pract Res Clin Gastroenterol (2005) 2.54
Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol (1997) 2.27
Increased migration and metastatic potential of tumor cells expressing aquaporin water channels. FASEB J (2006) 2.07
Evaluation of glucocorticoid-induced DNA fragmentation in mouse thymocytes by flow cytometry. Cell Prolif (1991) 1.60
AMPK promotes p53 acetylation via phosphorylation and inactivation of SIRT1 in liver cancer cells. Cancer Res (2012) 1.52
Endothelium specific Weibel-Palade bodies in a continuous human cell line, EA.hy926. In Vitro Cell Dev Biol (1990) 1.17
Cordycepin inhibits vascular smooth muscle cell proliferation. Eur J Pharmacol (2008) 1.16
Antitumor effect of cordycepin (3'-deoxyadenosine) on mouse melanoma and lung carcinoma cells involves adenosine A3 receptor stimulation. Anticancer Res (2006) 1.13
The apoptotic effect of cordycepin on human OEC-M1 oral cancer cell line. Cancer Chemother Pharmacol (2006) 1.13
Cordycepin, a metabolic product isolated from cultures of Cordyceps militaris (Linn.) Link. Nature (1950) 1.12
Cordycepin prevents hyperlipidemia in hamsters fed a high-fat diet via activation of AMP-activated protein kinase. J Pharmacol Sci (2010) 1.12
Inhibition of Ehrlich mouse ascites tumor growth by cordycepin. Cancer Res (1961) 1.11
Inhibitory effects of ethyl acetate extract of Cordyceps sinensis mycelium on various cancer cells in culture and B16 melanoma in C57BL/6 mice. Phytomedicine (2006) 1.08
Cordycepin-induced apoptosis and autophagy in breast cancer cells are independent of the estrogen receptor. Toxicol Appl Pharmacol (2011) 1.07
Antifungal activity of 3'-deoxyadenosine (cordycepin). Antimicrob Agents Chemother (1998) 1.06
Free radical scavenging and apoptotic effects of Cordyceps sinensis fractionated by supercritical carbon dioxide. Food Chem Toxicol (2005) 1.06
Cordycepin inhibits protein synthesis and cell adhesion through effects on signal transduction. J Biol Chem (2009) 1.03
Cordycepin causes p21WAF1-mediated G2/M cell-cycle arrest by regulating c-Jun N-terminal kinase activation in human bladder cancer cells. Arch Biochem Biophys (2009) 0.99
c-Jun N-terminal kinase 1 is required for cordycepin-mediated induction of G2/M cell-cycle arrest via p21WAF1 expression in human colon cancer cells. Food Chem Toxicol (2009) 0.96
Inhibition of migration and invasion of LNCaP human prostate carcinoma cells by cordycepin through inactivation of Akt. Int J Oncol (2012) 0.95
The proteasome is involved in angiogenesis. Biochem Biophys Res Commun (1998) 0.93
The role of cordycepin in cancer treatment via induction or inhibition of apoptosis: implication of polyadenylation in a cell type specific manner. Cancer Chemother Pharmacol (2007) 0.92
Hepatitis B virus and hepatocarcinogenesis. Ann Hepatol (2008) 0.92
Column chromatographic extraction and preparation of cordycepin from Cordyceps militaris waster medium. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 0.92
Chain termination and inhibition of mammalian poly(A) polymerase by modified ATP analogues. Biochem Pharmacol (2009) 0.92
Cordycepin/Hydroxyurea synergy allows low dosage efficacy of cordycepin in MOLT-4 leukemia cells. Anticancer Res (2007) 0.91
Proteomic detection of changes in protein expression induced by cordycepin in human hepatocellular carcinoma BEL-7402 cells. Methods Find Exp Clin Pharmacol (2008) 0.91
Effect of cordycepin (3'-deoxyadenosine) on hematogenic lung metastatic model mice. In Vivo (2005) 0.90
Pharmacokinetics of adenosine and cordycepin, a bioactive constituent of Cordyceps sinensis in rat. J Agric Food Chem (2010) 0.88
Protective effects of hyperoside (quercetin-3-o-galactoside) to PC12 cells against cytotoxicity induced by hydrogen peroxide and tert-butyl hydroperoxide. Biomed Pharmacother (2005) 0.88
Enhancement of the biological activity of adenosine analogs by the adenosine deaminase inhibitor 2'-deoxycoformycin. Pharmacology (1977) 0.86
An HPLC method for determination of inosine and hypoxanthine in human plasma from healthy volunteers and patients presenting with potential acute cardiac ischemia. J Chromatogr B Analyt Technol Biomed Life Sci (2007) 0.86
INHIBITION OF HUMAN TUMOR CELLS BY CORDYCEPIN. Biochim Biophys Acta (1965) 0.85
Biological behaviors and proteomics analysis of hybrid cell line EAhy926 and its parent cell line A549. J Exp Clin Cancer Res (2009) 0.80
Biosynthesis of 3'-deoxyadenosine by Cordyceps militaris. Mechanism of reduction. Biochim Biophys Acta (1976) 0.79
The antitumor activity of exogenous and endogenous canstatin on colorectal cancer cells. Asian Pac J Cancer Prev (2011) 0.79
Enhancement of radiation killing of cultured mammalian cells by cordycepin. Int J Radiat Biol Relat Stud Phys Chem Med (1978) 0.77
Angiogenesis research is on fast forward. J Natl Cancer Inst (1999) 0.77